{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:03:20Z","timestamp":1791925400117,"version":"4.3.4"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T00:00:00Z","timestamp":1497830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T00:00:00Z","timestamp":1497830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1038\/cmi.2017.35","type":"journal-article","created":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T04:40:29Z","timestamp":1497847229000},"page":"662-674","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":604,"title":["B cell regulation in cancer and anti-tumor immunity"],"prefix":"10.1038","volume":"14","author":[{"given":"Anushruti","family":"Sarvaria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Alejandro","family":"Madrigal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore","family":"Saudemont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,6,19]]},"reference":[{"key":"BFcmi201735_CR1","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Greten FR, Karin M . Immunity, inflammation, and cancer. Cell 2010; 140: 883\u2013899.","journal-title":"Cell"},{"key":"BFcmi201735_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2567.2007.02587.x","volume":"121","author":"R Kim","year":"2007","unstructured":"Kim R, Emi M, Tanabe K . Cancer immunoediting from immune surveillance to immune escape. Immunology 2007; 121: 1\u20134.","journal-title":"Immunology"},{"key":"BFcmi201735_CR3","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.yexcr.2013.03.005","volume":"319","author":"AJ Gunderson","year":"2013","unstructured":"Gunderson AJ, Coussens LM . B cells and their mediators as targets for therapy in solid tumors. Exp Cell Res 2013; 319: 1644\u20131649.","journal-title":"Exp Cell Res"},{"key":"BFcmi201735_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/978-3-0348-0706-7_2","volume-title":"Drugs Targeting B-Cells in Autoimmune Diseases","author":"MS Naradikian","year":"2014","unstructured":"Naradikian MS, Scholz JL, Oropallo MA, Cancro MP . Understanding B Cell Biology. Drugs Targeting B-Cells in Autoimmune Diseases. Springer: Basal, 2014, 11\u201335."},{"key":"BFcmi201735_CR5","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/nri3857","volume":"15","author":"P Shen","year":"2015","unstructured":"Shen P, Fillatreau S . Antibody-independent functions of B cells: a focus on cytokines. Nat Rev Immunol 2015; 15: 441\u2013451.","journal-title":"Nat Rev Immunol"},{"key":"BFcmi201735_CR6","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.coi.2008.03.014","volume":"20","author":"D Allman","year":"2008","unstructured":"Allman D, Pillai S . Peripheral B cell subsets. Curr Opin Immunol 2008; 20: 149\u2013157.","journal-title":"Curr Opin Immunol"},{"key":"BFcmi201735_CR7","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.0105-2896.2004.0109.x","volume":"197","author":"R Carsetti","year":"2004","unstructured":"Carsetti R, Rosado MM, Wardmann H . Peripheral development of B cells in mouse and man. Immunol Rev 2004; 197: 179\u2013191.","journal-title":"Immunol Rev"},{"key":"BFcmi201735_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.1600-065X.2010.00946.x","volume":"237","author":"T Kurosaki","year":"2010","unstructured":"Kurosaki T . B\u2010lymphocyte biology. Immunol Rev 2010; 237: 5\u20139.","journal-title":"Immunol Rev"},{"key":"BFcmi201735_CR9","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1182\/blood-2008-02-078071","volume":"112","author":"TW LeBien","year":"2008","unstructured":"LeBien TW, Tedder TF . B lymphocytes: how they develop and function. Blood 2008; 112: 1570\u20131580.","journal-title":"Blood"},{"key":"BFcmi201735_CR10","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jaci.2013.01.046","volume":"131","author":"K Pieper","year":"2013","unstructured":"Pieper K, Grimbacher B, Eibel H . B-cell biology and development. J Allergy Clin Immunol 2013; 131: 959\u2013971.","journal-title":"J Allergy Clin Immunol"},{"key":"BFcmi201735_CR11","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1146\/annurev.immunol.021908.132607","volume":"27","author":"JC Weill","year":"2009","unstructured":"Weill JC, Weller S, Reynaud CA . Human marginal zone B cells. Annu Rev Immunol 2009; 27: 267\u2013285.","journal-title":"Annu Rev Immunol"},{"key":"BFcmi201735_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2172-13-63","volume":"13","author":"O Garraud","year":"2012","unstructured":"Garraud O, Borhis G, Badr G, Degrelle S, Pozzetto B, Cognasse F et al. Revisiting the B-cell compartment in mouse and humans: more than one B-cell subset exists in the marginal zone and beyond. BMC Immunol 2012; 13: 1.","journal-title":"BMC Immunol"},{"key":"BFcmi201735_CR13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1365-2249.2012.04657.x","volume":"171","author":"K Oleinika","year":"2013","unstructured":"Oleinika K, Nibbs RJ, Graham GJ, Fraser AR . Suppression, subversion and escape: the role of regulatory T cells in cancer progression. Clin Exp Immunol 2013; 171: 36\u201345.","journal-title":"Clin Exp Immunol"},{"key":"BFcmi201735_CR14","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/nm0598-627","volume":"4","author":"Z Qin","year":"1998","unstructured":"Qin Z, Richter G, Sch\u00fcler T, Ibe S, Cao X, Blankenstein T . B cells inhibit induction of T cell-dependent tumor immunity. Nat Med 1998; 4: 627\u2013630.","journal-title":"Nat Med"},{"key":"BFcmi201735_CR15","doi-asserted-by":"publisher","first-page":"7741","DOI":"10.1158\/0008-5472.CAN-05-3766","volume":"66","author":"S Inoue","year":"2006","unstructured":"Inoue S, Leitner WW, Golding B, Scott D . Inhibitory effects of B cells on antitumor immunity. Cancer Res 2006; 66: 7741\u20137747.","journal-title":"Cancer Res"},{"key":"BFcmi201735_CR16","doi-asserted-by":"publisher","first-page":"e25443","DOI":"10.4161\/onci.25443","volume":"2","author":"C Fremd","year":"2013","unstructured":"Fremd C, Schuetz F, Sohn C, Beckhove P, Domschke C . B cell-regulated immune responses in tumor models and cancer patients. Oncoimmunology 2013; 2: e25443.","journal-title":"Oncoimmunology"},{"key":"BFcmi201735_CR17","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ccr.2005.04.014","volume":"7","author":"KE De Visser","year":"2005","unstructured":"De Visser KE, Korets LV, Coussens LM . De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 2005; 7: 411\u2013423.","journal-title":"Cancer Cell"},{"key":"BFcmi201735_CR18","doi-asserted-by":"publisher","first-page":"10662","DOI":"10.1073\/pnas.1100994108","volume":"108","author":"T Schioppa","year":"2011","unstructured":"Schioppa T, Moore R, Thompson RG, Rosser EC, Kulbe H, Nedospasov S et al. B regulatory cells and the tumor-promoting actions of TNF-\u03b1 during squamous carcinogenesis. Proc Natl Acad Sci USA 2011; 108: 10662\u201310667.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcmi201735_CR19","doi-asserted-by":"publisher","first-page":"4006","DOI":"10.4049\/jimmunol.0903009","volume":"184","author":"DJ DiLillo","year":"2010","unstructured":"DiLillo DJ, Yanaba K, Tedder TF . B cells are required for optimal CD4+ and CD8+ T cell tumor immunity: therapeutic B cell depletion enhances B16 melanoma growth in mice. J Immunol 2010; 184: 4006\u20134016.","journal-title":"J Immunol"},{"key":"BFcmi201735_CR20","doi-asserted-by":"publisher","first-page":"3195","DOI":"10.4049\/jimmunol.0803773","volume":"183","author":"Q Li","year":"2009","unstructured":"Li Q, Teitz-Tennenbaum S, Donald EJ, Li M, Chang AE . In vivo sensitized and in vitro activated B cells mediate tumor regression in cancer adoptive immunotherapy. J Immunol 2009; 183: 3195\u20133203.","journal-title":"J Immunol"},{"key":"BFcmi201735_CR21","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1158\/1078-0432.CCR-12-0234","volume":"18","author":"JS Nielsen","year":"2012","unstructured":"Nielsen JS, Sahota RA, Milne K, Kost SE, Nesslinger NJ, Watson PH et al. CD20+ tumor-infiltrating lymphocytes have an atypical CD27\u2212 memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer. Clin Cancer Res 2012; 18: 3281\u20133292.","journal-title":"Clin Cancer Res"},{"key":"BFcmi201735_CR22","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1084\/jem.20021293","volume":"197","author":"C Mauri","year":"2003","unstructured":"Mauri C, Gray D, Mushtaq N, Londei M . Prevention of arthritis by interleukin 10\u2013producing B cells. J Exp Med 2003; 197: 489\u2013501.","journal-title":"J Exp Med"},{"key":"BFcmi201735_CR23","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.immuni.2008.03.017","volume":"28","author":"K Yanaba","year":"2008","unstructured":"Yanaba K, Bouaziz JD, Haas KM, Poe JC, Fujimoto M, Tedder TF . A regulatory B cell subset with a unique CD1dhi CD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 2008; 28: 639\u2013650.","journal-title":"Immunity"},{"key":"BFcmi201735_CR24","doi-asserted-by":"publisher","first-page":"3492","DOI":"10.4049\/jimmunol.0803052","volume":"182","author":"PA Blair","year":"2009","unstructured":"Blair PA, Chavez-Rueda KA, Evans JG, Shlomchik MJ, Eddaoudi A, Isenberg DA et al. Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL\/lpr mice. J Immunol 2009; 182: 3492\u20133502.","journal-title":"J Immunol"},{"key":"BFcmi201735_CR25","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","volume":"32","author":"PA Blair","year":"2010","unstructured":"Blair PA, Nore\u00f1a LY, Flores-Borja F, Rawlings DJ, Isenberg DA, Ehrenstein MR et al. CD19+ CD24 hi CD38 hi B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity 2010; 32: 129\u2013140.","journal-title":"Immunity"},{"key":"BFcmi201735_CR26","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1182\/blood-2010-07-294249","volume":"117","author":"Y Iwata","year":"2011","unstructured":"Iwata Y, Matsushita T, Horikawa M, DiLillo DJ, Yanaba K, Venturi GM et al. Characterization of a rare IL-10\u2013competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood 2011; 117: 530\u2013541.","journal-title":"Blood"},{"key":"BFcmi201735_CR27","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1182\/blood-2014-04-571125","volume":"124","author":"A Khoder","year":"2014","unstructured":"Khoder A, Sarvaria A, Alsuliman A, Chew C, Sekine T, Cooper N et al. Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD. Blood 2014; 124: 2034\u20132045.","journal-title":"Blood"},{"key":"BFcmi201735_CR28","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","volume":"42","author":"EC Rosser","year":"2015","unstructured":"Rosser EC, Mauri C . Regulatory B cells: origin, phenotype, and function. Immunity 2015; 42: 607\u2013612.","journal-title":"Immunity"},{"key":"BFcmi201735_CR29","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1749-6632.2009.05137.x","volume":"1183","author":"DJ DiLillo","year":"2010","unstructured":"DiLillo DJ, Matsushita T, Tedder TF . B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann NY Acad Sci 2010; 1183: 38\u201357.","journal-title":"Ann NY Acad Sci"},{"key":"BFcmi201735_CR30","doi-asserted-by":"publisher","first-page":"5997","DOI":"10.1038\/ncomms6997","volume":"6","author":"AR Khan","year":"2015","unstructured":"Khan AR, Hams E, Floudas A, Sparwasser T, Weaver CT, Fallon PG . PD-L1hi B cells are critical regulators of humoral immunity. Nat Commun 2015; 6: 5997.","journal-title":"Nat Commun"},{"key":"BFcmi201735_CR31","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/251550a0","volume":"251","author":"SI Katz","year":"1974","unstructured":"Katz SI, Parker D, Turk JL . B-cell suppression of delayed hypersensitivity reactions. Nature 1974; 251: 550\u2013551.","journal-title":"Nature"},{"key":"BFcmi201735_CR32","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.4049\/jimmunol.113.6.1716","volume":"113","author":"R Neta","year":"1974","unstructured":"Neta R, Salvin SB . Specific suppression of delayed hypersensitivity: the possible presence of a suppressor B cell in the regulation of delayed hypersensitivity. J Immunol 1974; 113: 1716\u20131725.","journal-title":"J Immunol"},{"key":"BFcmi201735_CR33","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/0008-8749(82)90093-4","volume":"68","author":"T Shimamura","year":"1982","unstructured":"Shimamura T, Hashimoto K, Sasaki S . Feedback suppression of the immune response in vivo: I. Immune B cells induce antigen-specific suppressor T cells. Cell Immunol 1982; 68: 104\u2013113.","journal-title":"Cell Immunol"},{"key":"BFcmi201735_CR34","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0008-8749(84)90242-9","volume":"83","author":"T Shimamura","year":"1984","unstructured":"Shimamura T, Habu S, Hashimoto K, Sasaki S . Feedback suppression of the immune response in vivo: III. Lyt-1+ B cells are suppressor-inducer cells. Cell Immunol 1984; 83: 221\u2013224.","journal-title":"Cell Immunol"},{"key":"BFcmi201735_CR35","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S1074-7613(02)00274-1","volume":"16","author":"A Mizoguchi","year":"2002","unstructured":"Mizoguchi A, Mizoguchi E, Takedatsu H, Blumberg RS, Bhan AK . Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity 2002; 16: 219\u2013230.","journal-title":"Immunity"},{"key":"BFcmi201735_CR36","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/ni833","volume":"3","author":"S Fillatreau","year":"2002","unstructured":"Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM . B cells regulate autoimmunity by provision of IL-10. Nat Immunol 2002; 3: 944\u2013950.","journal-title":"Nat Immunol"},{"key":"BFcmi201735_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar3736","volume":"14","author":"NA Carter","year":"2012","unstructured":"Carter NA, Rosser EC, Mauri C . Interleukin-10 produced by B cells is crucial for the suppression of Th17\/Th1 responses, induction of T regulatory type 1 cells and reduction of collagen-induced arthritis. Arthritis Res Ther 2012; 14: 1.","journal-title":"Arthritis Res Ther"},{"key":"BFcmi201735_CR38","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.4049\/jimmunol.174.4.2429","volume":"174","author":"R Brummel","year":"2005","unstructured":"Brummel R, Lenert P . Activation of marginal zone B cells from lupus mice with type A (D) CpG-oligodeoxynucleotides. J Immunol 2005; 174: 2429\u20132434.","journal-title":"J Immunol"},{"key":"BFcmi201735_CR39","doi-asserted-by":"publisher","first-page":"3961","DOI":"10.4049\/jimmunol.1102880","volume":"188","author":"R Bankoti","year":"2012","unstructured":"Bankoti R, Gupta K, Levchenko A, St\u00e4ger S . Marginal zone B cells regulate antigen-specific T cell responses during infection. J Immunol 2012; 188: 3961\u20133971.","journal-title":"J Immunol"},{"key":"BFcmi201735_CR40","doi-asserted-by":"publisher","first-page":"5569","DOI":"10.4049\/jimmunol.1100284","volume":"186","author":"NA Carter","year":"2011","unstructured":"Carter NA, Vasconcellos R, Rosser EC, Tulone C, Mu\u00f1oz-Suano A, Kamanaka M et al. Mice lacking endogenous IL-10\u2013producing regulatory B cells develop exacerbated disease and present with an increased frequency of Th1\/Th17 but a decrease in regulatory T cells. J Immunol 2011; 186: 5569\u20135579.","journal-title":"J Immunol"},{"key":"BFcmi201735_CR41","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.1172\/JCI46274","volume":"121","author":"Q Ding","year":"2011","unstructured":"Ding Q, Yeung M, Camirand G, Zeng Q, Akiba H, Yagita H et al. Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice. J Clin Invest 2011; 121: 3645\u20133656.","journal-title":"J Clin Invest"},{"key":"BFcmi201735_CR42","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/nature12979","volume":"507","author":"P Shen","year":"2014","unstructured":"Shen P, Roch T, Lampropoulou V, O\u2019Connor RA, Stervbo U, Hilgenberg E et al. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature 2014; 507: 366\u2013370.","journal-title":"Nature"},{"key":"BFcmi201735_CR43","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.immuni.2014.10.016","volume":"41","author":"M Matsumoto","year":"2014","unstructured":"Matsumoto M, Baba A, Yokota T, Nishikawa H, Ohkawa Y, Kayama H et al. Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation. Immunity 2014; 41: 1040\u20131051.","journal-title":"Immunity"},{"key":"BFcmi201735_CR44","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/nm.2003","volume":"15","author":"M Rafei","year":"2009","unstructured":"Rafei M, Hsieh J, Zehntner S, Li M, Forner K, Birman E et al. A granulocyte-macrophage colony\u2013stimulating factor and interleukin-15 fusokine induces a regulatory B cell population with immune suppressive properties. Nat Med 2009; 15: 1038\u20131045.","journal-title":"Nat Med"},{"key":"BFcmi201735_CR45","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.4049\/jimmunol.1300649","volume":"191","author":"D Maseda","year":"2013","unstructured":"Maseda D, Candando KM, Smith SH, Kalampokis I, Weaver CT, Plevy SE et al. Peritoneal cavity regulatory B cells (B10 cells) modulate IFN-\u03b3+ CD4+ T cell numbers during colitis development in mice. J Immunol 2013; 191: 2780\u20132795.","journal-title":"J Immunol"},{"key":"BFcmi201735_CR46","doi-asserted-by":"publisher","first-page":"7459","DOI":"10.4049\/jimmunol.0900270","volume":"182","author":"K Yanaba","year":"2009","unstructured":"Yanaba K, Bouaziz JD, Matsushita T, Tsubata T, Tedder TF . The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. J Immunol 2009; 182: 7459\u20137472.","journal-title":"J Immunol"},{"key":"BFcmi201735_CR47","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/imr.12176","volume":"259","author":"KM Candando","year":"2014","unstructured":"Candando KM, Lykken JM, Tedder TF . B10 cell regulation of health and disease. Immunol Rev 2014; 259: 259\u2013272.","journal-title":"Immunol Rev"},{"key":"BFcmi201735_CR48","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/nature11501","volume":"491","author":"A Yoshizaki","year":"2012","unstructured":"Yoshizaki A, Miyagaki T, DiLillo DJ, Matsushita T, Horikawa M, Kountikov EI et al. Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature 2012; 491: 264\u2013268.","journal-title":"Nature"},{"key":"BFcmi201735_CR49","doi-asserted-by":"publisher","first-page":"7868","DOI":"10.4049\/jimmunol.178.12.7868","volume":"178","author":"JG Evans","year":"2007","unstructured":"Evans JG, Chavez-Rueda KA, Eddaoudi A, Meyer-Bahlburg A, Rawlings DJ, Ehrenstein MR et al. Novel suppressive function of transitional 2 B cells in experimental arthritis. J Immunol 2007; 178: 7868\u20137878.","journal-title":"J Immunol"},{"key":"BFcmi201735_CR50","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.4049\/jimmunol.1102500","volume":"188","author":"D Maseda","year":"2012","unstructured":"Maseda D, Smith SH, DiLillo DJ, Bryant JM, Candando KM, Weaver CT et al. Regulatory B10 cells differentiate into antibody-secreting cells after transient IL-10 production in vivo . J Immunol 2012; 188: 1036\u20131048.","journal-title":"J Immunol"},{"key":"BFcmi201735_CR51","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.celrep.2015.09.070","volume":"13","author":"J Sun","year":"2015","unstructured":"Sun J, Wang J, Pefanis E, Chao J, Rothschild G, Tachibana I et al. Transcriptomics identify CD9 as a marker of murine IL-10-competent regulatory B Cells. Cell Rep 2015; 13: 1110\u20131117.","journal-title":"Cell Rep"},{"key":"BFcmi201735_CR52","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nature14395","volume":"521","author":"S Shalapour","year":"2015","unstructured":"Shalapour S, Font-Burgada J, Di Caro G, Zhong Z, Sanchez-Lopez E, Dhar D et al. Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy. Nature 2015; 521: 94\u201398.","journal-title":"Nature"},{"key":"BFcmi201735_CR53","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4049\/jimmunol.190.Supp.185.16","volume":"190","author":"H Kaku","year":"2013","unstructured":"Kaku H, Cheng KF, Al Abed Y, Rothstein T . A novel mechanism of B-cell mediated immune suppression through adenosine production. J Immunol 2013; 190: 185\u2013186.","journal-title":"J Immunol"},{"key":"BFcmi201735_CR54","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1084\/jem.20062512","volume":"204","author":"S Deaglio","year":"2007","unstructured":"Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, Erat A et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 2007; 204: 1257\u20131265.","journal-title":"J Exp Med"},{"key":"BFcmi201735_CR55","doi-asserted-by":"publisher","first-page":"210","DOI":"10.4049\/jimmunol.1402453","volume":"194","author":"S Ganti","year":"2015","unstructured":"Ganti S, Albershardt T, Iritani B, Ruddell A . Regulatory B cells accumulate in tumor-draining lymph nodes and promote tumor growth (TUM9P. 1015). J Immunol 2015; 194: 210\u2013217.","journal-title":"J Immunol"},{"key":"BFcmi201735_CR56","doi-asserted-by":"publisher","first-page":"173ra23","DOI":"10.1126\/scitranslmed.3005407","volume":"5","author":"F Flores-Borja","year":"2013","unstructured":"Flores-Borja F, Bosma A, Ng D, Reddy V, Ehrenstein MR, Isenberg DA et al. CD19+ CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation. Sci Transl Med 2013; 5: 173ra23\u2013173ra23.","journal-title":"Sci Transl Med"},{"key":"BFcmi201735_CR57","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.4049\/jimmunol.1103139","volume":"189","author":"A Das","year":"2012","unstructured":"Das A, Ellis G, Pallant C, Lopes AR, Khanna P, Peppa D et al. IL-10\u2013producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection. J Immunol 2012; 189: 3925\u20133935.","journal-title":"J Immunol"},{"key":"BFcmi201735_CR58","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1182\/blood-2014-09-599159","volume":"125","author":"A de Masson","year":"2015","unstructured":"de Masson A, Bouaziz JD, Le Buanec H, Robin M, O\u2019Meara A, Parquet N et al. CD24hiCD27+ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease. Blood 2015; 125: 1830\u20131839.","journal-title":"Blood"},{"key":"BFcmi201735_CR59","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1158\/0008-5472.CAN-12-3450","volume":"73","author":"S Lindner","year":"2013","unstructured":"Lindner S, Dahlke K, Sontheimer K, Hagn M, Kaltenmeier C, Barth TF et al. Interleukin 21\u2013Induced Granzyme B\u2013Expressing B Cells Infiltrate Tumors and Regulate T Cells. Cancer Res 2013; 73: 2468\u20132479.","journal-title":"Cancer Res"},{"key":"BFcmi201735_CR60","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.jaci.2013.01.014","volume":"131","author":"W van de Veen","year":"2013","unstructured":"van de Veen W, Stanic B, Yaman G, Wawrzyniak M, S\u00f6llner S, Akdis DG et al. IgG 4 production is confined to human IL-10\u2013producing regulatory B cells that suppress antigen-specific immune responses. J Allergy Clin Immunol 2013; 131: 1204\u20131212.","journal-title":"J Allergy Clin Immunol"},{"key":"BFcmi201735_CR61","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1189\/jlb.0912436","volume":"93","author":"B Siewe","year":"2013","unstructured":"Siewe B, Stapleton JT, Martinson J, Keshavarzian A, Kazmi N, Demarais PM et al. Regulatory B cell frequency correlates with markers of HIV disease progression and attenuates anti-HIV CD8+ T cell function in vitro . J Leukoc Biol 2013; 93: 811\u2013818.","journal-title":"J Leukoc Biol"},{"key":"BFcmi201735_CR62","doi-asserted-by":"publisher","first-page":"e92934","DOI":"10.1371\/journal.pone.0092934","volume":"9","author":"B Siewe","year":"2014","unstructured":"Siewe B, Wallace J, Rygielski S, Stapleton JT, Martin J, Deeks SG et al. Regulatory B cells inhibit cytotoxic T lymphocyte (CTL) activity and elimination of infected CD4 T cells after in vitro reactivation of HIV latent reservoirs. PLoS One 2014; 9: e92934.","journal-title":"PLoS One"},{"key":"BFcmi201735_CR63","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1002\/eji.201040673","volume":"40","author":"JD Bouaziz","year":"2010","unstructured":"Bouaziz JD, Calbo S, Maho\u2010Vaillant M, Saussine A, Bagot M, Bensussan A et al. IL\u201010 produced by activated human B cells regulates CD4+ T\u2010cell activation in vitro . Eur J Immunol 2010; 40: 2686\u20132691.","journal-title":"Eur J Immunol"},{"key":"BFcmi201735_CR64","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jneuroim.2011.08.019","volume":"239","author":"S Knippenberg","year":"2011","unstructured":"Knippenberg S, Peelen E, Smolders J, Thewissen M, Menheere P, Tervaert JW et al. Reduction in IL-10 producing B cells (Breg) in multiple sclerosis is accompanied by a reduced naive\/memory Breg ratio during a relapse but not in remission. J Neuroimmunol 2011; 239: 80\u201386.","journal-title":"J Neuroimmunol"},{"key":"BFcmi201735_CR65","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1182\/blood-2016-01-695122","volume":"128","author":"A Sarvaria","year":"2016","unstructured":"Sarvaria A, Basar R, Mehta RS, Shaim H, Muftuoglu M, Khoder A et al. IL-10+ regulatory B cells are enriched in cord blood and may protect against cGVHD after cord blood transplantation. Blood 2016; 128: 1346\u20131361.","journal-title":"Blood"},{"key":"BFcmi201735_CR66","doi-asserted-by":"publisher","first-page":"e1082703","DOI":"10.1080\/2162402X.2015.1082703","volume":"5","author":"F Figueir\u00f3","year":"2016","unstructured":"Figueir\u00f3 F, Muller L, Funk S, Jackson EK, Battastini AM, Whiteside TL . Phenotypic and functional characteristics of CD39high human regulatory B cells (Breg). OncoImmunology 2016; 5: e1082703.","journal-title":"OncoImmunology"},{"key":"BFcmi201735_CR67","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.autrev.2011.11.018","volume":"11","author":"A Kessel","year":"2012","unstructured":"Kessel A, Haj T, Peri R, Snir A, Melamed D, Sabo E et al. Human CD19+ CD25 high B regulatory cells suppress proliferation of CD4+ T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells. Autoimmun Rev 2012; 11: 670\u2013677.","journal-title":"Autoimmun Rev"},{"key":"BFcmi201735_CR68","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.4049\/jimmunol.167.2.1081","volume":"167","author":"J Tian","year":"2001","unstructured":"Tian J, Zekzer D, Hanssen L, Lu Y, Olcott A, Kaufman DL . Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J Immunol 2001; 167: 1081\u20131089.","journal-title":"J Immunol"},{"key":"BFcmi201735_CR69","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1084\/jem.192.4.475","volume":"192","author":"V Moulin","year":"2000","unstructured":"Moulin V, Andris F, Thielemans K, Maliszewski C, Urbain J, Moser M . B Lymphocytes Regulate Dendritic Cell (Dc) Function in Vivo Increased Interleukin 12 Production by DCs from B Cell\u2013Deficient Mice Results in T Helper Cell Type 1 Deviation. J Exp Med 2000; 192: 475\u2013482.","journal-title":"J Exp Med"},{"key":"BFcmi201735_CR70","doi-asserted-by":"publisher","first-page":"33486","DOI":"10.18632\/oncotarget.5588","volume":"6","author":"WW Wang","year":"2015","unstructured":"Wang WW, Yuan XL, Chen H, Xie GH, Ma YH, Zheng YX et al. CD19+ CD24hiCD38hiBregs involved in downregulate helper T cells and upregulate regulatory T cells in gastric cancer. Oncotarget 2015; 6: 33486\u201333499.","journal-title":"Oncotarget"},{"key":"BFcmi201735_CR71","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.biocel.2014.10.005","volume":"57","author":"S Han","year":"2014","unstructured":"Han S, Feng S, Ren M, Ma E, Wang X, Xu L et al. Glioma cell-derived placental growth factor induces regulatory B cells. Int J Biochem Cell Biol 2014; 57: 63\u201368.","journal-title":"Int J Biochem Cell Biol"},{"key":"BFcmi201735_CR72","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1182\/blood-2006-03-014001","volume":"108","author":"B Jahrsd\u00f6rfer","year":"2006","unstructured":"Jahrsd\u00f6rfer B, Blackwell SE, Wooldridge JE, Huang J, Andreski MW, Jacobus LS et al. B-chronic lymphocytic leukemia cells and other B cells can produce granzyme B and gain cytotoxic potential after interleukin-21-based activation. Blood 2006; 108: 2712\u20132719.","journal-title":"Blood"},{"key":"BFcmi201735_CR73","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.immuni.2012.02.008","volume":"36","author":"A Bosma","year":"2012","unstructured":"Bosma A, Abdel-Gadir A, Isenberg DA, Jury EC, Mauri C . Lipid-antigen presentation by CD1d+ B cells is essential for the maintenance of invariant natural killer T cells. Immunity 2012; 36: 477\u2013490.","journal-title":"Immunity"},{"key":"BFcmi201735_CR74","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1164\/rccm.201010-1738OC","volume":"183","author":"R Sorrentino","year":"2011","unstructured":"Sorrentino R, Morello S, Forte G, Montinaro A, Vita GD, Luciano A et al. B cells contribute to the antitumor activity of CpG-oligodeoxynucleotide in a mouse model of metastatic lung carcinoma. Am J Respir Crit Care Med 2011; 183: 1369\u20131379.","journal-title":"Am J Respir Crit Care Med"},{"key":"BFcmi201735_CR75","first-page":"4","volume":"8","author":"HP Jones","year":"2008","unstructured":"Jones HP, Wang YC, Aldridge B, Weiss JM . Lung and splenic B cells facilitate diverse effects on in vitro measures of antitumor immune responses. Cancer Immun 2008; 8: 4.","journal-title":"Cancer Immun"},{"key":"BFcmi201735_CR76","first-page":"992","volume":"18","author":"N Kaliss","year":"1958","unstructured":"Kaliss N . Immunological Enhancement of Tumor Homografts in Mice A Review. Cancer Res 1958; 18: 992\u20131003.","journal-title":"Cancer Res"},{"key":"BFcmi201735_CR77","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/ijc.2910090126","volume":"9","author":"M Ran","year":"1972","unstructured":"Ran M, Witz IP . Tumor\u2010associated immunoglobulins. Enhancement of syngeneic tumors by IgG2\u2010containing tumor eluates. Int J Cancer 1972; 9: 242\u2013247.","journal-title":"Int J Cancer"},{"key":"BFcmi201735_CR78","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/BF00205312","volume":"13","author":"P Brodt","year":"1982","unstructured":"Brodt P, Gordon J . Natural resistance mechanisms may play a role in protection against chemical carcinogenesis. Cancer Immunol Immunother 1982; 13: 125\u2013127.","journal-title":"Cancer Immunol Immunother"},{"key":"BFcmi201735_CR79","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ccr.2009.12.019","volume":"17","author":"P Andreu","year":"2010","unstructured":"Andreu P, Johansson M, Affara NI, Pucci F, Tan T, Junankar S et al. FcR\u03b3 activation regulates inflammation-associated squamous carcinogenesis. Cancer Cell 2010; 17: 121\u2013134.","journal-title":"Cancer Cell"},{"key":"BFcmi201735_CR80","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/nature08782","volume":"464","author":"M Ammirante","year":"2010","unstructured":"Ammirante M, Luo JL, Grivennikov S, Nedospasov S, Karin M . B-cell-derived lymphotoxin promotes castration-resistant prostate cancer. Nature 2010; 464: 302\u2013305.","journal-title":"Nature"},{"key":"BFcmi201735_CR81","doi-asserted-by":"publisher","first-page":"e64159","DOI":"10.1371\/journal.pone.0064159","volume":"8","author":"C Yang","year":"2013","unstructured":"Yang C, Lee H, Pal S, Jove V, Deng J, Zhang W et al. B cells promote tumor progression via STAT3 regulated-angiogenesis. PloS One 2013; 8: e64159.","journal-title":"PloS One"},{"key":"BFcmi201735_CR82","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/PL00006672","volume":"48","author":"E Barbera-Guillem","year":"2000","unstructured":"Barbera-Guillem E, Nelson MB, Barr B, Nyhus JK, May Jr KF, Feng L et al. B lymphocyte pathology in human colorectal cancer. Experimental and clinical therapeutic effects of partial B cell depletion. Cancer Immunol Immunother 2000; 48: 541\u2013549.","journal-title":"Cancer Immunol Immunother"},{"key":"BFcmi201735_CR83","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1002\/ijc.21177","volume":"117","author":"S Shah","year":"2005","unstructured":"Shah S, Divekar AA, Hilchey SP, Cho HM, Newman CL, Shin SU et al. Increased rejection of primary tumors in mice lacking B cells: Inhibition of anti\u2010tumor CTL and TH1 cytokine responses by B cells. Int J Cancer 2005; 117: 574\u2013586.","journal-title":"Int J Cancer"},{"key":"BFcmi201735_CR84","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1158\/0008-5472.CAN-07-5688","volume":"68","author":"JM Park","year":"2008","unstructured":"Park JM, Terabe M, Steel JC, Forni G, Sakai Y, Morris JC et al. Therapy of advanced established murine breast cancer with a recombinant adenoviral ErbB-2\/neu vaccine. Cancer Res 2008; 68: 1979\u20131987.","journal-title":"Cancer Res"},{"key":"BFcmi201735_CR85","doi-asserted-by":"publisher","first-page":"5220","DOI":"10.1158\/1078-0432.CCR-08-0133","volume":"14","author":"KI Al-Shibli","year":"2008","unstructured":"Al-Shibli KI, Donnem T, Al-Saad S, Persson M, Bremnes RM, Busund LT . Prognostic effect of epithelial and stromal lymphocyte infiltration in non\u2013small cell lung cancer. Clin Cancer Res 2008; 14: 5220\u20135227.","journal-title":"Clin Cancer Res"},{"key":"BFcmi201735_CR86","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ygyno.2007.08.089","volume":"108","author":"BS Nedergaard","year":"2008","unstructured":"Nedergaard BS, Ladekarl M, Nyengaard JR, Nielsen K . A comparative study of the cellular immune response in patients with stage IB cervical squamous cell carcinoma. Low numbers of several immune cell subtypes are strongly associated with relapse of disease within 5 years. Gynecol Oncol 2008; 108: 106\u2013111.","journal-title":"Gynecol Oncol"},{"key":"BFcmi201735_CR87","doi-asserted-by":"publisher","first-page":"892","DOI":"10.4049\/jimmunol.173.2.892","volume":"173","author":"TJ Kemp","year":"2004","unstructured":"Kemp TJ, Moore JM, Griffith TS . Human B cells express functional TRAIL\/Apo-2 ligand after CpG-containing oligodeoxynucleotide stimulation. J Immunol 2004; 173: 892\u2013899.","journal-title":"J Immunol"},{"key":"BFcmi201735_CR88","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1309\/15B66DQMFYYM78CJ","volume":"125","author":"HP Dong","year":"2006","unstructured":"Dong HP, Elstrand MB, Holth A, Silins I, Berner A, Trope CG et al. NK-and B-cell infiltration correlates with worse outcome in metastatic ovarian carcinoma. Am J Clin Pathol 2006; 125: 451\u2013458.","journal-title":"Am J Clin Pathol"},{"key":"BFcmi201735_CR89","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13048-016-0232-0","volume":"9","author":"S Lundgren","year":"2016","unstructured":"Lundgren S, Berntsson J, Nodin B, Micke P, Jirstr\u00f6m K . Prognostic impact of tumour-associated B cells and plasma cells in epithelial ovarian cancer. J Ovarian Res 2016; 9: 21.","journal-title":"J Ovarian Res"},{"key":"BFcmi201735_CR90","doi-asserted-by":"publisher","first-page":"8420","DOI":"10.1158\/0008-5472.CAN-09-1627","volume":"69","author":"C Domschke","year":"2009","unstructured":"Domschke C, Schuetz F, Ge Y, Seibel T, Falk C, Brors B et al. Intratumoral cytokines and tumor cell biology determine spontaneous breast cancer\u2013specific immune responses and their correlation to prognosis. Cancer Res 2009; 69: 8420\u20138428.","journal-title":"Cancer Res"},{"key":"BFcmi201735_CR91","doi-asserted-by":"publisher","first-page":"4268","DOI":"10.1172\/JCI59266","volume":"121","author":"M Horikawa","year":"2011","unstructured":"Horikawa M, Minard-Colin V, Matsushita T, Tedder TF . Regulatory B cell production of IL-10 inhibits lymphoma depletion during CD20 immunotherapy in mice. J Clin Invest 2011; 121: 4268\u20134280.","journal-title":"J Clin Invest"},{"key":"BFcmi201735_CR92","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1158\/0008-5472.CAN-12-4184","volume":"73","author":"M Bodogai","year":"2013","unstructured":"Bodogai M, Chang CL, Wejksza K, Lai J, Merino M, Wersto RP et al. Anti-CD20 antibody promotes cancer escape via enrichment of tumor-evoked regulatory B cells expressing low levels of CD20 and CD137L. Cancer Res 2013; 73: 2127\u20132138.","journal-title":"Cancer Res"},{"key":"BFcmi201735_CR93","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1182\/blood-2008-01-135160","volume":"112","author":"V Minard-Colin","year":"2008","unstructured":"Minard-Colin V, Xiu Y, Poe JC, Horikawa M, Magro CM, Hamaguchi Y et al. Lymphoma depletion during CD20 immunotherapy in mice is mediated by macrophage Fc\u03b3RI, Fc\u03b3RIII, and Fc\u03b3RIV. Blood 2008; 112: 1205\u20131213.","journal-title":"Blood"},{"key":"BFcmi201735_CR94","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1093\/annonc\/mdh280","volume":"15","author":"M Aklilu","year":"2004","unstructured":"Aklilu M, Stadler WM, Markiewicz M, Vogelzang NJ, Mahowald M, Johnson M et al. Depletion of normal B cells with rituximab as an adjunct to IL-2 therapy for renal cell carcinoma and melanoma. Ann Oncol 2004; 15: 1109\u20131114.","journal-title":"Ann Oncol"},{"key":"BFcmi201735_CR95","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/intimm\/dxw007","volume":"28","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Morgan R, Chen C, Cai Y, Clark E, Khan WN et al. Mammary-tumor-educated B cells acquire LAP\/TGF-\u03b2 and PD-L1 expression and suppress anti-tumor immune responses. Int Immunol 2016; 28: 423\u2013433.","journal-title":"Int Immunol"},{"key":"BFcmi201735_CR96","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00262-012-1313-6","volume":"62","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Eliav Y, Shin SU, Schreiber TH, Podack ER, Tadmor T et al. B lymphocyte inhibition of anti-tumor response depends on expansion of Treg but is independent of B-cell IL-10 secretion. Cancer Immunol Immunother 2013; 62: 87\u201399.","journal-title":"Cancer Immunol Immunother"},{"key":"BFcmi201735_CR97","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1158\/0008-5472.CAN-10-4316","volume":"71","author":"PB Olkhanud","year":"2011","unstructured":"Olkhanud PB, Damdinsuren B, Bodogai M, Gress RE, Sen R, Wejksza K et al. Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4+ T cells to T-regulatory cells. Cancer Res 2011; 71: 3505\u20133515.","journal-title":"Cancer Res"},{"key":"BFcmi201735_CR98","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.4049\/jimmunol.1201920","volume":"190","author":"K Wejksza","year":"2013","unstructured":"Wejksza K, Lee-Chang C, Bodogai M, Bonzo J, Gonzalez FJ, Lehrmann E et al. Cancer-produced metabolites of 5-lipoxygenase induce tumor-evoked regulatory B cells via peroxisome proliferator\u2013activated receptor \u03b1. J Immunol 2013; 190: 2575\u20132584.","journal-title":"J Immunol"},{"key":"BFcmi201735_CR99","doi-asserted-by":"publisher","first-page":"263","DOI":"10.5114\/ceji.2015.52840","volume":"40","author":"L Qian","year":"2015","unstructured":"Qian L, Bian GR, Zhou Y, Wang Y, Hu J, Liu X et al. Clinical significance of regulatory B cells in the peripheral blood of patients with oesophageal cancer. Cent Eur J Immunol 2015; 40: 263\u2013265.","journal-title":"Cent Eur J Immunol"},{"key":"BFcmi201735_CR100","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.immuni.2016.04.003","volume":"44","author":"C Zhang","year":"2016","unstructured":"Zhang C, Xin H, Zhang W, Yazaki PJ, Zhang Z, Le K et al. CD5 binds to interleukin-6 and induces a feed-forward loop with the transcription factor STAT3 in B cells to promote cancer. Immunity 2016; 44: 913\u2013923.","journal-title":"Immunity"},{"key":"BFcmi201735_CR101","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.humimm.2015.10.015","volume":"77","author":"J Liu","year":"2016","unstructured":"Liu J, Wang H, Yu Q, Zheng S, Jiang Y, Liu Y et al. Aberrant frequency of IL-10-producing B cells and its association with Treg and MDSC cells in Non Small Cell Lung Carcinoma patients. Hum Immunol 2016; 77: 84\u201389.","journal-title":"Hum Immunol"},{"key":"BFcmi201735_CR102","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.oraloncology.2015.11.003","volume":"53","author":"X Zhou","year":"2016","unstructured":"Zhou X, Su YX, Lao XM, Liang YJ, Liao GQ . CD19+ IL-10+ regulatory B cells affect survival of tongue squamous cell carcinoma patients and induce resting CD4+ T cells to CD4+ Foxp3+ regulatory T cells. Oral Oncol 2016; 53: 27\u201335.","journal-title":"Oral Oncol"},{"key":"BFcmi201735_CR103","first-page":"1","volume":"37","author":"X Wei","year":"2016","unstructured":"Wei X, Jin Y, Tian Y, Zhang H, Wu J, Lu W et al. Regulatory B cells contribute to the impaired antitumor immunity in ovarian cancer patients. Tumour Biol 2016; 37: 1\u20138.","journal-title":"Tumour Biol"},{"key":"BFcmi201735_CR104","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/bcj.2017.24","volume":"7","author":"L Zhang","year":"2017","unstructured":"Zhang L, Tai YT, Ho M, Xing L, Chauhan D, Gang A et al. Regulatory B cell-myeloma cell interaction confers immunosuppression and promotes their survival in the bone marrow milieu. Blood Cancer J 2017; 7: 547.","journal-title":"Blood Cancer J"},{"key":"BFcmi201735_CR105","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1158\/2159-8290.CD-15-1408","volume":"6","author":"X Xiao","year":"2016","unstructured":"Xiao X, Lao XM, Chen MM, Liu RX, Wei Y, Ouyang FZ et al. PD-1hi Identifies a Novel Regulatory B-cell Population in Human Hepatoma That Promotes Disease Progression. Cancer Discov 2016; 6: 546\u2013559.","journal-title":"Cancer Discov"},{"key":"BFcmi201735_CR106","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.humimm.2009.10.003","volume":"71","author":"JC Lin","year":"2010","unstructured":"Lin JC, Shih YL, Chien PJ, Liu CL, Lee JJ, Liu TP et al. Increased percentage of B cells in patients with more advanced hepatocellular carcinoma. Hum Immunol 2010; 71: 58\u201362.","journal-title":"Hum Immunol"},{"key":"BFcmi201735_CR107","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.canlet.2014.09.026","volume":"355","author":"Y Shao","year":"2014","unstructured":"Shao Y, Lo CM, Ling CC, Liu XB, Ng KT, Chu AC et al. Regulatory B cells accelerate hepatocellular carcinoma progression via CD40\/CD154 signaling pathway. Cancer Lett 2014; 355: 264\u2013272.","journal-title":"Cancer Lett"}],"container-title":["Cellular & Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cmi201735.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cmi201735","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/cmi.2017.35","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/cmi201735.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T22:25:15Z","timestamp":1692829515000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cmi201735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,19]]},"references-count":107,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["BFcmi201735"],"URL":"https:\/\/doi.org\/10.1038\/cmi.2017.35","relation":{},"ISSN":["1672-7681","2042-0226"],"issn-type":[{"value":"1672-7681","type":"print"},{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,19]]},"assertion":[{"value":"26 November 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}